TMS in California will have Medicaid coverage for major depressive disorder patients
Medi-Cal’s new policy will cover more patients with MDD who do not respond adequately to antidepressants.
Neurology
PathMaker secures funding from US DoD for neuromodulation ALS trial
Neuralink’s first brain chip implant faces setback
Soterix Medical introduces electrical stimulation and EEG system
Magnus Medical rolls out neuromodulation system in US
Neuromodulation to see market growth, pioneering technology for epilepsy
Hyperfine starts enrolment in portable imaging workflow study
Roche wins breakthrough designation for Tau biomarker test for Alzheimer’s
